Searched over 200M research papers
10 papers analyzed
These studies suggest that unstable angina pectoris is a serious condition often requiring hospitalization and can be managed with medical or surgical therapy, with varying outcomes depending on the presence of significant coronary artery disease and patient age.
19 papers analyzed
Unstable angina pectoris (UAP) is a critical condition that lies between stable angina and acute myocardial infarction. It is characterized by sudden chest pain or discomfort that occurs at rest or with minimal exertion and is a significant predictor of acute myocardial infarction or sudden death . The condition is often classified into three categories: new-onset angina, angina of changing pattern, and angina occurring at rest.
Several studies have compared the effectiveness of medical and surgical treatments for UAP. A national cooperative study involving 150 patients found that both medical and surgical groups had similar clinical presentations and outcomes, suggesting that randomization is a rational method for selecting therapy. Another study with 50 patients revealed that while surgical treatment provided better pain relief, the 1.5-year survival rates were not significantly different between the medical and surgical groups. However, a significant portion of medically treated patients experienced recurrent UAP within a few months.
The After Eighty study focused on patients aged 80 years or older with non-ST-elevation myocardial infarction (NSTEMI) or UAP. It found that an invasive strategy, which includes early coronary angiography and possible revascularization, was superior to a conservative strategy in reducing composite events such as myocardial infarction, urgent revascularization, stroke, and death. The study highlighted that the invasive approach did not result in higher bleeding complications compared to the conservative approach.
A randomized, placebo-controlled trial investigated the use of recombinant human tissue-type plasminogen activator (rt-PA) in patients with UAP. The study found that rt-PA significantly reduced the persistence of UAP and the presence of subocclusive thrombus compared to placebo. This suggests that rt-PA could be an effective treatment option for reducing ischemic events in UAP patients.
Clinical and angiographic studies have provided insights into the coronary anatomy of UAP patients. One study involving 57 patients found that a majority had significant coronary artery obstruction, with a high incidence of multivessel disease. Another study with 75 patients identified a predominance of single-vessel disease, particularly involving the left anterior descending artery, in those with new-onset UAP.
The advent of more sensitive troponin assays has significantly influenced the diagnosis and classification of acute coronary syndromes. A study evaluating the impact of these assays found that the proportion of patients diagnosed with UAP has declined, while the diagnosis of NSTEMI has increased. Despite this shift, NSTEMI patients continue to have a higher mortality rate compared to those with UAP or STEMI.
Unstable angina pectoris remains a complex and critical condition requiring careful management. Both medical and surgical therapies have their merits, and the choice of treatment should be individualized based on patient characteristics and risk factors. In elderly patients, an invasive strategy appears to offer better outcomes. The use of rt-PA shows promise in reducing ischemic events, and sensitive troponin assays have refined the diagnosis and management of acute coronary syndromes. Ongoing research and clinical trials will continue to enhance our understanding and treatment of this challenging condition.
Most relevant research papers on this topic